Create and review regulatory documentation for Drug, Device and Combination product renewals and other life cycle maintenance-related submissions. Track status and progress of regulatory documentation.
Masters Degree in Biotechnology, Microbiology, Biochemistry, Life Sciences, Botany, Plant Science from a recognized University or equivalent. Understanding the molecular mechanism underlying seed-anociated endophytes regulated seed germination process of Himalayan medicinal plants and their application in food crops as synthetic microbial communities for stress tolerance
Diploma course in Pharmacy from an institution recognized by Government of India and the Pharmacy Council of India. Must have registered with Assam Pharmacy Council and should possess valid professional Pharmacist License.
Haryana Kaushal Rozgar Nigam Limited has been incorporated under the Companies Act, 2013 on 13th October, 2021. It has been set up with the objective of providing contractual manpower to all Government entities in Haryana in a transparent, robust and equitable manner. It will act as the authorized agency for providing contractual manpower in Haryana.
M.Sc. Degree in Clinical Trial abd Research, Pharmacology, Biostatistics, Biochemistry, Pharmaceutical Sciences or or equivalent qualification from a recognized University, Institution OR M.Sc. Clinical Research with experience in teaching, research in niversity, college and or research experience at equivalent level with at least 3 publications in National, International Journals
M.Sc, Integrated M.Sc. in Botany, Biotechnology, Microbiology, Biochemistry, Bioinformatics, Life Sciences or B.Tech. in Computer Science from recognized University.
Work on research project entitled Engineering hybrid biological systems for self-sustainable treatment of persistent mobile chemicals in common effluent treatment plant wastewater funded by Gujarat State Biotechnology Mission, Govt. of Gujarat at Gujarat M.Sc Biotechnology, Microbiology, Biochemistry or relevant life science discipline with minimum of 55% marks. Biotechnology University.
Candidates having M.Sc. or an equivalent qualification in Life Sciences or related subjects Biotechnology, Biochemistry, Genetics, Microbiology, Bioinformatics with a minimum of 60% marks or an equivalent grade point relaxation will be as per Govt. guideline are eligible to apply.
Post-graduate degree in Basic Sciences or Professional Courses.
Candidates with 1-2 years of hands-on experience in mammalian cell culture, stem cell culture, molecular biology, RNA isolation/western blotting, FACS, microscopy imaging techniques are preferred. Those with experience in zebrafish and mouse model may also apply.
Lab Exposure, Analytical Method Validation. Review of Specification. Method of Analysis Protocol Handing of 00S and 00T. Investigation and Lab event. Review & Approval of QC Documents. Knowledge of Qualification and Validation related Activities. Audit Trail Review etc
Experience in pharmacovigilance, in clinical care, or in clinical or scientific research is an advantage but not a requirement. Demonstrated computer literacy, particularly in the use and management of relational databases.
Execute the Formulation Technology Transfer activities across all Cipla sites and CMO to standardize, strengthen and improve the technology transfer processes and systems in line with regulations
A new variant of human mpox has claimed the lives of approximately 5% of people with reported infections in the Democratic Republic of the Congo since 2023, many of them children. Since then, it has spread to several other countries. The World Health Organization declared the outbreak a Public Health Emergency of International Concern on August 14. In addition, a different but rarely fatal mpox variant was responsible for an outbreak that has spread to more than 100 countries since 2022.
RNA-based technology facilitates effective use for difficult-to-treat, large-gene diseases. Gene therapy can effectively treat various diseases, but for some debilitating conditions like muscular dystrophies there is a big problem: size. The genes that are dysfunctional in muscular dystrophies are often extremely large, and current delivery methods can’t courier such substantial genetic loads into the body.
Sandoz the global leader in generic and biosimilar medicines, today announced that the European Commission (EC) has granted marketing authorization for Afqlir® (aflibercept) 2 mg vial kit and pre-filled syringe for intravitreal injection, a biosimilar to reference medicine Eylea®. Afqlir® is indicated to treat various retinal diseases, including neovascular age-related macular degeneration (nAMD), aiming to prevent disease-related blindness.
MBBS, BDS or M.Pharma, MPT, M.Sc. Nursing, Pharma.D. or Graduation in Science BAMS, BHMS, B.Sc. Nursing, B.Pharma from recognized University with three years of experience from the recognized Institute.
Design and fabricate sensors in the chemical engineering lab, followed by the use of actuators for pumping drugs in pre-selected doses based on algorithms. Generating models of neurological disorders and evaluating the sensitivity and accuracy using surgical techniques
Graduate in relevant subject, field B.Pharm, Life Science, B.Sc., Biotech, Zoology, Botany plus Three years experience is mandatory OR Postgraduate in relevant field M.Pharm, Life Science, M.Sc., Biotech, Zoology, Botany.
ECHS Invites applications to engage following Medical, Para Medical and Non-Metrical Staff or contractual basis in ECHS Polyclinic Vadodara and Surat Interested candidates who fulfil the qualifications may apply for the following vacant posts.